{"transactions":[{"id":690675,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock","published_at":"2026-08-11T20:21:36.000Z","date":"2026-08-08","kind":"exercise","planned":false,"acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":19624,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000897069-26-001602","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001602/form4.xml","form_type":"4"}},{"id":690674,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-11T20:21:36.000Z","date":"2026-08-08","kind":"exercise","planned":false,"acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":17092,"source":{"system":"sec-edgar","filing":"0000897069-26-001602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001602/form4.xml","form_type":"4"}},{"id":700517,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":25886,"kind":"person","name":"GUJRATHI SHEILA","position":1,"cik":"0001575202","reported_name":"GUJRATHI SHEILA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-07-31T01:49:56.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":12311.279,"ownership":{"direct":false,"nature":"By SilverArc Private Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Received in exchange for shares of common stock of Vidya Therapeutics, Inc. (\"Vidya\") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the \"Merger Agreement\"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (\"Merger Sub I\"), Venus Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (\"Merger Sub II\"), at an exchange ratio of 162.811 shares of Vidya common stock for each share of Company common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with Merger Sub II surviving the second merger as a wholly owned subsidiary of the Company (such mergers, the \"Merger\"). Upon the closing of the Merger, shares of outstanding common stock of Vidya converted into the right to receive shares of the Company's Series A Preferred Stock in accordance with the Merger Agreement. Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock, each share of Series A Preferred Stock is convertible into 1,000 shares of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for shares of common stock of Vidya Therapeutics, Inc. (\"Vidya\") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the \"Merger Agreement\"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (\"Merger Sub I\"), Venus Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (\"Merger Sub II\"), at an exchange ratio of 162.811 shares of Vidya common stock for each share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with Merger Sub II surviving the second merger as a wholly owned subsidiary of the Company (such mergers, the \"Merger\"). Upon the closing of the Merger, shares of outstanding common stock of Vidya converted into the right to receive shares of the Company's Series A Preferred Stock in accordance with the Merger Agreement. Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock, each share of Series A Preferred Stock is convertible into 1,000 shares of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is Co-Portfolio Manager and has membership interest in SilverArc Private Capital I, LLC (Ultimate General Partner), SilverArc Private Capital I, LP (General Partner), and SilverArc Private Capital Management I, LP (Management Company) for SilverArc Private Fund I, L.P. The Reporting Person may not be deemed to have voting or investment power over the shares held of record by SilverArc Private Fund I, LP. The Reporting Person disclaims beneficial ownership of such securities held of record by SilverArc Private Fund I, L.P., except to the extent of any pecuniary interest therein."}],"balance_after":12311.279,"derivative":{"underlying":"Common Stock","underlying_shares":12311.279},"source":{"system":"sec-edgar","filing":"0001575202-26-000011","document":"form4-07312026_010752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000157520226000011/form4-07312026_010752.xml","form_type":"4"}},{"id":700516,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":25886,"kind":"person","name":"GUJRATHI SHEILA","position":1,"cik":"0001575202","reported_name":"GUJRATHI SHEILA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-07-31T01:49:56.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":70811.877,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Received in exchange for shares of common stock of Vidya Therapeutics, Inc. (\"Vidya\") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the \"Merger Agreement\"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (\"Merger Sub I\"), Venus Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (\"Merger Sub II\"), at an exchange ratio of 162.811 shares of Vidya common stock for each share of Company common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with Merger Sub II surviving the second merger as a wholly owned subsidiary of the Company (such mergers, the \"Merger\"). Upon the closing of the Merger, shares of outstanding common stock of Vidya converted into the right to receive shares of the Company's Series A Preferred Stock in accordance with the Merger Agreement. Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock, each share of Series A Preferred Stock is convertible into 1,000 shares of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for shares of common stock of Vidya Therapeutics, Inc. (\"Vidya\") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the \"Merger Agreement\"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (\"Merger Sub I\"), Venus Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (\"Merger Sub II\"), at an exchange ratio of 162.811 shares of Vidya common stock for each share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with Merger Sub II surviving the second merger as a wholly owned subsidiary of the Company (such mergers, the \"Merger\"). Upon the closing of the Merger, shares of outstanding common stock of Vidya converted into the right to receive shares of the Company's Series A Preferred Stock in accordance with the Merger Agreement. Subject to certain conditions set forth in the Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock, each share of Series A Preferred Stock is convertible into 1,000 shares of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Non-Voting Convertible Preferred Stock (the \"Series A Preferred Stock\") is convertible into 1,000 shares of common stock of Processa Pharmaceuticals, Inc. (the \"Company\"). The Preferred Stock has no expiration date."}],"balance_after":70811.877,"derivative":{"underlying":"Common Stock","underlying_shares":70811.877},"source":{"system":"sec-edgar","filing":"0001575202-26-000011","document":"form4-07312026_010752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000157520226000011/form4-07312026_010752.xml","form_type":"4"}},{"id":702065,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:31:10.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":38749,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0000897069-26-001560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001560/form4.xml","form_type":"4"}},{"id":702124,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:29:23.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":11883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":17323,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11883},"source":{"system":"sec-edgar","filing":"0000897069-26-001558","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001558/form4.xml","form_type":"4"}},{"id":702251,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:27:52.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":38749,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0000897069-26-001556","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706926001556/form4.xml","form_type":"4"}},{"id":702185,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:26:33.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":9384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":21224,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9384},"source":{"system":"sec-edgar","filing":"0000897069-26-001554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001554/form4.xml","form_type":"4"}},{"id":702060,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:25:04.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":62221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":67470,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62221},"source":{"system":"sec-edgar","filing":"0000897069-26-001552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001552/form4.xml","form_type":"4"}},{"id":702225,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:23:51.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":11389,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000897069-26-001550","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001550/form4.xml","form_type":"4"}},{"id":702226,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:22:26.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":11669,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0000897069-26-001548","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001548/form4.xml","form_type":"4"}},{"id":702198,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:19:12.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":38749,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0000897069-26-001546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706926001546/form4.xml","form_type":"4"}},{"id":721313,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:20:40.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":2436,"price":1.93,"value":4701.48,"ownership":{"direct":true},"balance_after":14394,"source":{"system":"sec-edgar","filing":"0000897069-26-001484","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001484/form4.xml","form_type":"4"}},{"id":721312,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-07-01T20:19:50.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":2106,"price":1.93,"value":4064.58,"ownership":{"direct":true},"balance_after":13113,"source":{"system":"sec-edgar","filing":"0000897069-26-001482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001482/form4.xml","form_type":"4"}},{"id":721192,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:19:02.000Z","date":"2026-07-01","kind":"purchase","planned":false,"acquired":true,"shares":3057,"price":1.93,"value":5900.01,"ownership":{"direct":true},"balance_after":15492,"source":{"system":"sec-edgar","filing":"0000897069-26-001480","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001480/form4.xml","form_type":"4"}},{"id":720846,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:17:52.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":3277,"price":1.93,"value":6324.61,"ownership":{"direct":true},"balance_after":16689,"source":{"system":"sec-edgar","filing":"0000897069-26-001478","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001478/form4.xml","form_type":"4"}},{"id":720802,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-07-01T20:16:17.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":2531,"price":1.93,"value":4884.83,"ownership":{"direct":true},"balance_after":21729,"source":{"system":"sec-edgar","filing":"0000897069-26-001476","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926001476/form4.xml","form_type":"4"}},{"id":722641,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:49:50.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001472/form4.xml","form_type":"4"}},{"id":722640,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:49:50.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":353,"source":{"system":"sec-edgar","filing":"0000897069-26-001472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001472/form4.xml","form_type":"4"}},{"id":722890,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:48:04.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001470","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706926001470/form4.xml","form_type":"4"}},{"id":722889,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:48:04.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":2391,"source":{"system":"sec-edgar","filing":"0000897069-26-001470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706926001470/form4.xml","form_type":"4"}},{"id":722619,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:47:07.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001468/form4.xml","form_type":"4"}},{"id":722618,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:47:07.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":1021,"source":{"system":"sec-edgar","filing":"0000897069-26-001468","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001468/form4.xml","form_type":"4"}},{"id":722785,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:46:11.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001466","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706926001466/form4.xml","form_type":"4"}},{"id":722784,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:46:11.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":2528,"source":{"system":"sec-edgar","filing":"0000897069-26-001466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706926001466/form4.xml","form_type":"4"}},{"id":735951,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-06-16T20:24:24.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":2067,"price":2.22,"value":4588.74,"ownership":{"direct":true},"balance_after":19198,"source":{"system":"sec-edgar","filing":"0000897069-26-001414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926001414/form4.xml","form_type":"4"}},{"id":735972,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-16T20:23:10.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":2654,"price":2.22,"value":5891.88,"ownership":{"direct":true},"balance_after":13412,"source":{"system":"sec-edgar","filing":"0000897069-26-001412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001412/form4.xml","form_type":"4"}},{"id":736141,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-16T20:22:10.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":2465,"price":2.22,"value":5472.3,"ownership":{"direct":true},"balance_after":12435,"source":{"system":"sec-edgar","filing":"0000897069-26-001410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001410/form4.xml","form_type":"4"}},{"id":736254,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-06-16T20:21:08.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":1831,"price":2.22,"value":4064.82,"ownership":{"direct":true},"balance_after":11007,"source":{"system":"sec-edgar","filing":"0000897069-26-001408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001408/form4.xml","form_type":"4"}},{"id":736256,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-06-16T20:20:04.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":2118,"price":2.22,"value":4701.96,"ownership":{"direct":true},"balance_after":11958,"source":{"system":"sec-edgar","filing":"0000897069-26-001406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001406/form4.xml","form_type":"4"}},{"id":756799,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-06-01T21:01:39.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":1786,"price":2.57,"value":4590.02,"ownership":{"direct":true},"balance_after":17131,"source":{"system":"sec-edgar","filing":"0000897069-26-001295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926001295/form4.xml","form_type":"4"}},{"id":756812,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:59:56.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":2292,"price":2.57,"value":5890.44,"ownership":{"direct":true},"balance_after":10758,"source":{"system":"sec-edgar","filing":"0000897069-26-001293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001293/form4.xml","form_type":"4"}},{"id":757041,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:58:18.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":2129,"price":2.57,"value":5471.53,"ownership":{"direct":true},"balance_after":9970,"source":{"system":"sec-edgar","filing":"0000897069-26-001291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001291/form4.xml","form_type":"4"}},{"id":757112,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-06-01T20:56:53.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":1582,"price":2.57,"value":4065.74,"ownership":{"direct":true},"balance_after":9176,"source":{"system":"sec-edgar","filing":"0000897069-26-001289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001289/form4.xml","form_type":"4"}},{"id":757114,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:55:44.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":1829,"price":2.57,"value":4700.53,"ownership":{"direct":true},"balance_after":9840,"source":{"system":"sec-edgar","filing":"0000897069-26-001287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001287/form4.xml","form_type":"4"}},{"id":772009,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-19T22:06:01.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1843,"price":2.97,"value":5473.71,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 15 shares."}],"balance_after":7841,"source":{"system":"sec-edgar","filing":"0000897069-26-001186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001186/form4.xml","form_type":"4"}},{"id":771445,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-05-19T22:04:44.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1545,"price":2.97,"value":4588.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 13 shares."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0000897069-26-001184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926001184/form4.xml","form_type":"4"}},{"id":772180,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-05-19T22:02:07.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1369,"price":2.97,"value":4065.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 11 shares."}],"balance_after":7594,"source":{"system":"sec-edgar","filing":"0000897069-26-001182","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001182/form4.xml","form_type":"4"}},{"id":772181,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:37:16.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1583,"price":2.97,"value":4701.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 13 shares."}],"balance_after":8011,"source":{"system":"sec-edgar","filing":"0000897069-26-001176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001176/form4.xml","form_type":"4"}},{"id":771533,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:35:26.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1984,"price":2.97,"value":5892.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 16 shares."}],"balance_after":8466,"source":{"system":"sec-edgar","filing":"0000897069-26-001171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001171/form4.xml","form_type":"4"}},{"id":772008,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:31:29.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1843,"price":2.97,"value":5473.71,"ownership":{"direct":true},"balance_after":3979,"source":{"system":"sec-edgar","filing":"0000897069-26-001167","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001167/form4a.xml","form_type":"4/A","original_submission_date":"2026-04-17"}},{"id":772179,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:17:20.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1971,"price":2.71,"value":5341.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares adjusted to correct immaterial errors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares adjusted to correct immaterial errors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors."}],"balance_after":7481,"source":{"system":"sec-edgar","filing":"0000897069-26-001154","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926001154/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-01"}},{"id":795346,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-05-01T20:39:37.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1706,"price":2.69,"value":4589.14,"ownership":{"direct":true},"balance_after":13813,"source":{"system":"sec-edgar","filing":"0000897069-26-001010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926001010/form4.xml","form_type":"4"}},{"id":795379,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:38:35.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":2190,"price":2.69,"value":5891.1,"ownership":{"direct":true},"balance_after":6498,"source":{"system":"sec-edgar","filing":"0000897069-26-001008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001008/form4.xml","form_type":"4"}},{"id":795605,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:37:24.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":2034,"price":2.69,"value":5471.46,"ownership":{"direct":true},"balance_after":6013,"source":{"system":"sec-edgar","filing":"0000897069-26-001006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926001006/form4.xml","form_type":"4"}},{"id":795775,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-05-01T20:36:26.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1511,"price":2.69,"value":4064.59,"ownership":{"direct":true},"balance_after":6236,"source":{"system":"sec-edgar","filing":"0000897069-26-001004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926001004/form4.xml","form_type":"4"}},{"id":795776,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:35:41.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1748,"price":2.69,"value":4702.12,"ownership":{"direct":true},"balance_after":6441,"source":{"system":"sec-edgar","filing":"0000897069-26-001002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926001002/form4.xml","form_type":"4"}},{"id":795774,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:34:34.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1986,"price":2.69,"value":5342.34,"ownership":{"direct":true},"balance_after":7496,"source":{"system":"sec-edgar","filing":"0000897069-26-001000","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926001000/form4.xml","form_type":"4"}},{"id":796828,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:33:51.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1843,"price":2.97,"value":5473.71,"ownership":{"direct":true},"balance_after":3979,"source":{"system":"sec-edgar","filing":"0000897069-26-000979","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926000979/form4a.xml","form_type":"4/A","original_submission_date":"2026-04-17"}},{"id":796827,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:32:54.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2136,"price":2.535,"value":5414.76,"ownership":{"direct":true},"balance_after":2136,"source":{"system":"sec-edgar","filing":"0000897069-26-000977","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926000977/form4a.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":805262,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-04-17T20:55:16.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1545,"price":2.97,"value":4588.65,"ownership":{"direct":true},"balance_after":12107,"source":{"system":"sec-edgar","filing":"0000897069-26-000912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926000912/form4.xml","form_type":"4"}},{"id":805611,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:54:02.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1843,"price":2.97,"value":5473.71,"ownership":{"direct":true},"balance_after":5492,"source":{"system":"sec-edgar","filing":"0000897069-26-000910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926000910/form4.xml","form_type":"4"}},{"id":805677,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-04-17T20:52:50.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1369,"price":2.97,"value":4065.93,"ownership":{"direct":true},"balance_after":4725,"source":{"system":"sec-edgar","filing":"0000897069-26-000908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926000908/form4.xml","form_type":"4"}},{"id":805678,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:51:42.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1583,"price":2.97,"value":4701.51,"ownership":{"direct":true},"balance_after":4693,"source":{"system":"sec-edgar","filing":"0000897069-26-000906","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926000906/form4.xml","form_type":"4"}},{"id":805676,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:50:19.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1799,"price":2.97,"value":5343.03,"ownership":{"direct":true},"balance_after":5510,"source":{"system":"sec-edgar","filing":"0000897069-26-000904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000904/form4.xml","form_type":"4"}},{"id":805282,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:49:16.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1984,"price":2.97,"value":5892.48,"ownership":{"direct":true},"balance_after":4308,"source":{"system":"sec-edgar","filing":"0000897069-26-000902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926000902/form4.xml","form_type":"4"}},{"id":819029,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T21:12:17.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":789,"price":2.535,"value":2000.115,"ownership":{"direct":true},"balance_after":818,"source":{"system":"sec-edgar","filing":"0000897069-26-000781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926000781/form4.xml","form_type":"4"}},{"id":822616,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-04-01T21:20:16.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1810,"price":2.535,"value":4588.35,"ownership":{"direct":true},"balance_after":10562,"source":{"system":"sec-edgar","filing":"0000897069-26-000756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926000756/form4.xml","form_type":"4"}},{"id":822649,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:18:31.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2324,"price":2.535,"value":5891.34,"ownership":{"direct":true},"balance_after":2324,"source":{"system":"sec-edgar","filing":"0000897069-26-000754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926000754/form4.xml","form_type":"4"}},{"id":822967,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:17:03.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2072,"price":2.535,"value":5252.52,"ownership":{"direct":true},"balance_after":2188,"source":{"system":"sec-edgar","filing":"0000897069-26-000752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706926000752/form4.xml","form_type":"4"}},{"id":822838,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:15:37.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2136,"price":2.535,"value":5414.76,"ownership":{"direct":true},"balance_after":3649,"source":{"system":"sec-edgar","filing":"0000897069-26-000750","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706926000750/form4.xml","form_type":"4"}},{"id":822934,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-04-01T21:11:24.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1603,"price":2.535,"value":4063.605,"ownership":{"direct":true},"balance_after":3356,"source":{"system":"sec-edgar","filing":"0000897069-26-000747","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926000747/form4.xml","form_type":"4"}},{"id":822935,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:09:45.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1854,"price":2.535,"value":4699.89,"ownership":{"direct":true},"balance_after":3110,"source":{"system":"sec-edgar","filing":"0000897069-26-000745","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926000745/form4.xml","form_type":"4"}},{"id":822933,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:08:25.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2107,"price":2.535,"value":5341.245,"ownership":{"direct":true},"balance_after":3711,"source":{"system":"sec-edgar","filing":"0000897069-26-000743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000743/form4.xml","form_type":"4"}},{"id":822868,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:06:41.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2269,"price":2.535,"value":5751.915,"ownership":{"direct":true},"balance_after":2325,"source":{"system":"sec-edgar","filing":"0000897069-26-000741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706926000741/form4.xml","form_type":"4"}},{"id":919162,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T22:09:36.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":49,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":49},"source":{"system":"sec-edgar","filing":"0000897069-26-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926000224/form4.xml","form_type":"4"}},{"id":919161,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Research & Development"}}],"security":"Common Stock","published_at":"2026-02-04T22:09:36.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":49,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":8752,"source":{"system":"sec-edgar","filing":"0000897069-26-000224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706926000224/form4.xml","form_type":"4"}},{"id":919498,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-02-04T22:07:34.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":193},"source":{"system":"sec-edgar","filing":"0000897069-26-000222","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926000222/form4.xml","form_type":"4"}},{"id":919497,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business - Strategy Off"}}],"security":"Common Stock","published_at":"2026-02-04T22:07:34.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":1753,"source":{"system":"sec-edgar","filing":"0000897069-26-000222","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706926000222/form4.xml","form_type":"4"}},{"id":919500,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T22:05:30.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":193},"source":{"system":"sec-edgar","filing":"0000897069-26-000220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926000220/form4.xml","form_type":"4"}},{"id":919499,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-02-04T22:05:30.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":1256,"source":{"system":"sec-edgar","filing":"0000897069-26-000220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706926000220/form4.xml","form_type":"4"}},{"id":919496,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T22:04:07.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":249},"source":{"system":"sec-edgar","filing":"0000897069-26-000218","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000218/form4.xml","form_type":"4"}},{"id":919495,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T22:04:07.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":1604,"source":{"system":"sec-edgar","filing":"0000897069-26-000218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706926000218/form4.xml","form_type":"4"}},{"id":1024131,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:41:27.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001561","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001561/form4.xml","form_type":"4"}},{"id":1024130,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:41:27.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001561","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001561/form4.xml","form_type":"4"}},{"id":1024586,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:39:25.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001559","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706925001559/form4.xml","form_type":"4"}},{"id":1024585,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:39:25.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001559","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706925001559/form4.xml","form_type":"4"}},{"id":1024733,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:36:43.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001557","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706925001557/form4.xml","form_type":"4"}},{"id":1024732,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:36:43.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001557","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706925001557/form4.xml","form_type":"4"}},{"id":1024241,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:34:50.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925001555/form4.xml","form_type":"4"}},{"id":1024240,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:34:50.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925001555/form4.xml","form_type":"4"}},{"id":1024697,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:33:01.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":150000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000897069-25-001553","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706925001553/form4.xml","form_type":"4"}},{"id":1024696,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:33:01.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":50000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000897069-25-001553","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706925001553/form4.xml","form_type":"4"}},{"id":1024695,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"officer":true,"officer_title":"Chief Business - Strategy Off"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:31:12.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":204000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0000897069-25-001551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706925001551/form4.xml","form_type":"4"}},{"id":1024694,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"officer":true,"officer_title":"Chief Business - Strategy Off"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:31:12.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":68000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0000897069-25-001551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706925001551/form4.xml","form_type":"4"}},{"id":1024693,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:29:49.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":288000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":288000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":288000},"source":{"system":"sec-edgar","filing":"0000897069-25-001549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001549/form4.xml","form_type":"4"}},{"id":1024692,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:29:49.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":96000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000897069-25-001549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001549/form4.xml","form_type":"4"}},{"id":1024268,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:27:52.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":324000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":324000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":324000},"source":{"system":"sec-edgar","filing":"0000897069-25-001547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001547/form4.xml","form_type":"4"}},{"id":1024267,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:27:52.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":108000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0000897069-25-001547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001547/form4.xml","form_type":"4"}},{"id":1024193,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"officer_title":"Pres. Research & Development"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:25:21.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":333000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":333000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":333000},"source":{"system":"sec-edgar","filing":"0000897069-25-001545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706925001545/form4.xml","form_type":"4"}},{"id":1024192,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":33834,"kind":"person","name":"Young David","position":1,"cik":"0001378166","reported_name":"Young David","relationship":{"director":true,"officer":true,"officer_title":"Pres. Research & Development"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:25:21.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":111000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0000897069-25-001545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378166/000089706925001545/form4.xml","form_type":"4"}},{"id":1024519,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:23:59.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":768000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":768000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":768000},"source":{"system":"sec-edgar","filing":"0000897069-25-001543","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706925001543/form4.xml","form_type":"4"}},{"id":1024518,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":24591,"kind":"person","name":"Ng George K","position":1,"cik":"0001638744","reported_name":"Ng George K","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:23:59.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":256000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":256000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":256000},"source":{"system":"sec-edgar","filing":"0000897069-25-001543","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638744/000089706925001543/form4.xml","form_type":"4"}},{"id":1036393,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28268,"kind":"person","name":"Pannu Geraldine","position":1,"cik":"0001817209","reported_name":"Pannu Geraldine","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-09-18T20:22:26.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024."}],"balance_after":36275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-25-001500","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817209/000089706925001500/form4.xml","form_type":"4/A","original_submission_date":"2025-07-28"}},{"id":1036141,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-09-18T20:19:51.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024."}],"balance_after":36275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-25-001496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001496/form4.xml","form_type":"4/A","original_submission_date":"2025-07-28"}},{"id":1036352,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28258,"kind":"person","name":"Baluch Khoso","position":1,"cik":"0001686223","reported_name":"Baluch Khoso","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-09-18T20:12:36.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024."}],"balance_after":36275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-25-001488","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686223/000089706925001488/form4.xml","form_type":"4/A","original_submission_date":"2025-07-28"}},{"id":1080660,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28265,"kind":"person","name":"Guy Wendy","position":1,"cik":"0001799360","reported_name":"Guy Wendy","relationship":{"officer":true,"officer_title":"Chief Administrative Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:36:46.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1366046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,349,245 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1376478,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1366046},"source":{"system":"sec-edgar","filing":"0000897069-25-001223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799360/000089706925001223/form4.xml","form_type":"4"}},{"id":1080659,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28264,"kind":"person","name":"Lin Patrick","position":1,"cik":"0001799363","reported_name":"Lin Patrick","relationship":{"officer":true,"officer_title":"Chief Business - Strategy Off"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:34:38.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1401650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,384,411 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1412082,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1401650},"source":{"system":"sec-edgar","filing":"0000897069-25-001221","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799363/000089706925001221/form4.xml","form_type":"4"}},{"id":1080658,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":46000,"kind":"person","name":"Bigora Sian","position":1,"cik":"0001799365","reported_name":"Bigora Sian","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:32:43.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1659185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,638,778 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1672087,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1659185},"source":{"system":"sec-edgar","filing":"0000897069-25-001219","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799365/000089706925001219/form4.xml","form_type":"4"}},{"id":1080527,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:30:16.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1775044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,753,212 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1803044,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1775044},"source":{"system":"sec-edgar","filing":"0000897069-25-001217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001217/form4.xml","form_type":"4"}}],"next_cursor":"2025-07-28T20:30:16.000000Z,1080527"}